Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia
Rhabdomyolysis is a life-threatening syndrome due to breakdown of the skeletal muscle. It can be caused by massive trauma and crush injuries or occur as a side effect of medications. Here, we describe a case of a 33-year-old male with human immunodeficiency virus (HIV) and newly diagnosed chronic my...
Saved in:
| Main Authors: | Andrew Stevenson Joel Chandranesan, Samip Master, Olivia Antosz, Breanne PeytonThomas, Nebu Koshy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2018/2849869 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of dasatinib in chronic myeloid leukemia therapy
by: O. Yu. Vinogradova, et al.
Published: (2008-12-01) -
Successful Pregnancy and Delivery in a Patient with Chronic
Myeloid Leukemia while on Dasatinib Therapy
by: Monika Conchon, et al.
Published: (2010-01-01) -
Neutrophilic eccrine hidradenitis following dasatinib initiation in a patient with chronic myeloid leukemia
by: Avery Watson, M4, et al.
Published: (2025-07-01) -
Dasatinib in core‐binding factor acute myeloid leukemia: A promising therapeutic approach
by: Shyam Srinivasan
Published: (2024-10-01) -
Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life
by: TI Ionova, et al.
Published: (2017-04-01)